Phase I Dose Escalation of Pazopanib Plus TH302 in Advanced Solid Tumors Followed by an Expanded Cohort in Pancreatic Neuroendocrine Tumors.
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2011
At a glance
- Drugs Evofosfamide; Pazopanib
- Indications Neuroendocrine tumours; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2011 New trial record